scispace - formally typeset
Journal ArticleDOI

Development of a Pilot Scale Process for the Anti-Alzheimer Drug (−)-Galanthamine Using Large-Scale Phenolic Oxidative Coupling and Crystallisation-Induced Chiral Conversion

TLDR
(−)-Galanthamine has been synthesised using an efficient nine-step procedure, which in large scale affords 12.4 (6.7−19.1)% overall yield.
About
This article is published in Organic Process Research & Development.The article was published on 1999-11-04. It has received 113 citations till now.

read more

Citations
More filters
Journal ArticleDOI

Discovery and resupply of pharmacologically active plant-derived natural products: A review.

TL;DR: While the intrinsic complexity of natural product-based drug discovery necessitates highly integrated interdisciplinary approaches, the reviewed scientific developments, recent technological advances, and research trends clearly indicate that natural products will be among the most important sources of new drugs in the future.
Journal ArticleDOI

Large-Scale Carbonyl Reductions in the Pharmaceutical Industry

TL;DR: The most common and reliable methods for the reduction of aldehydes, ketones, carboxylic acids, esters, amides, imides, and acid chlorides are discussed.
Journal ArticleDOI

Reductive Amination in the Synthesis of Pharmaceuticals.

TL;DR: This Review concisely compiles information on 71 medical substances that are synthesized by reductive amination according to the principle of action and a general synthetic scheme is provided for each compound.
References
More filters
Journal ArticleDOI

New kilogram-synthesis of the anti-alzheimer drug (−)-galanthamine

TL;DR: In this paper, a scalable synthesis of (−)-galanthamine, a drug being used for the treatment of Alzheimer's disease, was described, and the yield of the critical phenolic coupling step was optimized to 45-50%.
Journal ArticleDOI

An improved synthesis of galanthamine

TL;DR: In this paper, modifications in the total synthesis of the Amarylidaceae alkaloid of galanthamine from commercially available isovanillin and tyramine have resulted in a shortened reaction sequence, which is amenable to upscaling and in improved product yield.
Journal ArticleDOI

Reversal of central anticholinergic syndrome by galanthamine.

Anis Baraka, +1 more
- 21 Nov 1977 - 
TL;DR: Galanthamine produces effective, safe, and long-lasting reversal of the central anticholinergic syndrome in man.
Related Papers (5)